{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:30:20Z","timestamp":1783017020124,"version":"3.54.6"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG083512"],"award-info":[{"award-number":["R01AG083512"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bmcl.2026.130712","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T06:32:43Z","timestamp":1781159563000},"page":"130712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identification of a novel a\u03b2-overlapping binding site on the TREM2 Ectodomain engaged by the small-molecule agonist VG-3927"],"prefix":"10.1016","volume":"139","author":[{"given":"Sungwoo","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moustafa T.","family":"Gabr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2026.130712_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/nrn.2016.7","article-title":"TREM2 variants: new keys to decipher Alzheimer disease pathogenesis","author":"Colonna","year":"2016","journal-title":"Nat Rev Neurosci."},{"issue":"11","key":"10.1016\/j.bmcl.2026.130712_bb0010","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","article-title":"TREM2 - a key player in microglial biology and Alzheimer disease","volume":"14","author":"Ulland","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.bmcl.2026.130712_bb0015","article-title":"TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1","volume":"3(122):ra38. Epub 20100518","author":"Peng","year":"2010","journal-title":"Sci Signal"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130712_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.07.023","article-title":"TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease","volume":"170","author":"Ulland","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bmcl.2026.130712_bb0025","series-title":"The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity. Immunity","author":"Filipello","year":"2018"},{"key":"10.1016\/j.bmcl.2026.130712_bb0030","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1211851","article-title":"Alzheimer Genetic Analysis G. TREM2 variants in Alzheimer\u2019s disease","author":"Guerreiro","year":"2013","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bmcl.2026.130712_bb0035","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer\u2019s disease","author":"Jonsson","year":"2013","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bmcl.2026.130712_bb0040","article-title":"TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model","author":"Wang","year":"2015","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bmcl.2026.130712_bb0045","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","article-title":"TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-Beta by microglia","volume":"91","author":"Yeh","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.bmcl.2026.130712_bb0050","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M115.679043","article-title":"Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)","author":"Atagi","year":"2015","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130712_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2018.01.031","article-title":"TREM2 is a receptor for beta-amyloid that mediates microglial function","volume":"97","author":"Zhao","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.bmcl.2026.130712_bb0060","series-title":"TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration. Nat Neurosci","author":"Xie","year":"2022"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130712_bb0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13024-018-0247-7","article-title":"Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2)","volume":"13","author":"Zhong","year":"2018","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.bmcl.2026.130712_bb0070","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.20391","article-title":"Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms","volume":"5","author":"Kober","year":"2016","journal-title":"Elife"},{"issue":"32","key":"10.1016\/j.bmcl.2026.130712_bb0075","doi-asserted-by":"crossref","first-page":"12634","DOI":"10.1074\/jbc.RA118.002352","article-title":"Molecular basis for the loss-of-function effects of the Alzheimer\u2019s disease-associated R47H variant of the immune receptor TREM2","volume":"293","author":"Sudom","year":"2018","journal-title":"J Biol Chem."},{"issue":"1","key":"10.1016\/j.bmcl.2026.130712_bb0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-024-00795-9","article-title":"Biophysical mapping of TREM2-ligand interactions reveals shared surfaces for engagement of multiple Alzheimer\u2019s disease ligands","volume":"20","author":"Greven","year":"2025","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.bmcl.2026.130712_bb0085","article-title":"Structural and functional analysis of TREM2 interactions with amyloid beta reveal molecular mechanisms that mediate phagocytosis of oligomeric amyloid beta","author":"Greven","year":"2024","journal-title":"bioRxiv"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130712_bb0090","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","article-title":"TREM2 Haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy","volume":"90","author":"Yuan","year":"2016","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.bmcl.2026.130712_bb0095","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200785","article-title":"Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model","volume":"217","author":"Wang","year":"2020","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130712_bb0100","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2114486119","article-title":"Soluble TREM2 inhibits secondary nucleation of Abeta fibrillization and enhances cellular uptake of fibrillar Abeta","volume":"119","author":"Belsare","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"issue":"S6","key":"10.1016\/j.bmcl.2026.130712_bb0105","article-title":"Pharmacological and functional characterization of the first small molecule TREM2 agonist, VG-3927, for the treatment of Alzheimer\u2019s disease","volume":"20","author":"Mirescu","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"S6","key":"10.1016\/j.bmcl.2026.130712_bb0110","article-title":"Characterization of the first TREM2 small molecule agonist, VG-3927, for clinical development in Alzheimer\u2019s disease","volume":"20","author":"Mirescu","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.bmcl.2026.130712_bb0115","doi-asserted-by":"crossref","DOI":"10.1021\/acsmedchemlett.5c00299","article-title":"Discovery of a Small Molecule TREM2 Agonist with Improved In Vitro Pharmacokinetic Profile and Validated Target Engagement","author":"Yuan","year":"2025","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2026.130712_bb0120","article-title":"DiffDock: diffusion steps, twists, and turns for molecular docking","author":"Corso","year":"2022","journal-title":"ArXiv"},{"key":"10.1016\/j.bmcl.2026.130712_bb0125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.molstruc.2014.03.009","article-title":"MicroScale thermophoresis: interaction analysis and beyond","volume":"1077","author":"Jerabek-Willemsen","year":"2014","journal-title":"J Mol Struct"},{"issue":"17","key":"10.1016\/j.bmcl.2026.130712_bb0130","first-page":"1631","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"Reply N Engl J Med"},{"issue":"6","key":"10.1016\/j.bmcl.2026.130712_bb0135","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26001794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26001794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:31:46Z","timestamp":1783013506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X26001794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":27,"alternative-id":["S0960894X26001794"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130712","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a novel a\u03b2-overlapping binding site on the TREM2 Ectodomain engaged by the small-molecule agonist VG-3927","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130712","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130712"}}